Gassert Chad, SVP of Corporate Development and Strategy at ANI Pharmaceuticals ($ANIP), sold about $3.05 million in company shares across three open market transactions over the past year. His most recent sale occurred on November 13, 2025. These sales rank 2,686th among 11,678 individual insiders in our database, where the average is $8.6 million across roughly 6.4 transactions. Chad made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | F | Common Stock | 2221 | $73.90 | 233,406.0000 | 23,076,000 | 0.94% | 0.01% |
| Feb. 26, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | A | Common Stock | 11116 | $77.15 | 235,627.0000 | 23,076,000 | 4.95% | 0.05% |
| Feb. 14, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | F | Common Stock | 1717 | $77.36 | 224,511.0000 | 23,076,000 | 0.76% | 0.01% |
| Feb. 12, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | F | Common Stock | 1608 | $76.70 | 226,228.0000 | 23,076,000 | 0.71% | 0.01% |
| Feb. 11, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | F | Common Stock | 4269 | $76.25 | 227,836.0000 | 23,076,000 | 1.84% | 0.02% |
| Nov. 13, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 94 | $88.00 | 232,105.0000 | 23,076,000 | 0.04% | 0.00% |
| Nov. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 14642 | $89.07 | 232,199.0000 | 23,076,000 | 5.93% | 0.06% |
| Aug. 15, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $86.97 | 246,841.0000 | 22,322,000 | 7.50% | 0.09% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | A | Common Stock | 14362 | $0.00 | 257,267.0000 | 21,538,000 | 5.91% | 0.07% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | A | Common Stock | 9574 | $0.00 | 266,841.0000 | 21,538,000 | 3.72% | 0.04% |
| July 1, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $63.44 | 242,905.0000 | 21,476,000 | 7.61% | 0.09% |
| June 3, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $64.41 | 262,905.0000 | 20,731,000 | 7.07% | 0.10% |
| May 1, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $66.62 | 282,905.0000 | 20,731,000 | 6.60% | 0.10% |
| April 1, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $67.25 | 302,905.0000 | 20,731,000 | 6.19% | 0.10% |
| March 11, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $65.81 | 322,905.0000 | 20,731,000 | 5.83% | 0.10% |
| Feb. 29, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | F | Common Stock | 1635 | $67.67 | 342,905.0000 | 20,731,000 | 0.47% | 0.01% |
| Feb. 14, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | A | Common Stock | 13421 | $0.00 | 335,594.0000 | 20,731,000 | 4.17% | 0.06% |
| Feb. 14, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | A | Common Stock | 8946 | $0.00 | 344,540.0000 | 20,731,000 | 2.67% | 0.04% |
| Oct. 2, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $56.48 | 322,173.0000 | 17,644,000 | 5.84% | 0.11% |
| Sept. 1, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $64.70 | 342,173.0000 | 17,644,000 | 5.52% | 0.11% |
| Aug. 1, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $51.06 | 362,173.0000 | 17,644,000 | 5.23% | 0.11% |
| July 3, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $53.43 | 382,173.0000 | 17,644,000 | 4.97% | 0.11% |
| June 22, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | S | Common Stock | 20000 | $51.32 | 402,173.0000 | 17,644,000 | 4.74% | 0.11% |
| Feb. 28, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | A | Common Stock | 11578 | $0.00 | 422,173.0000 | 17,644,000 | 2.82% | 0.07% |
| Feb. 28, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gassert Chad | SVP - CORP. DEV. & STRATEGY | A | Common Stock | 17369 | $0.00 | 410,595.0000 | 17,644,000 | 4.42% | 0.10% |